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We congratulate the authors of the recent articles on the
Oxford classification of IgA nephropathy (IgAN) on their
rigorous scientific approach.1,2 Our preliminary results in a
study of IgAN broadly support their findings. However we
would like to make two additional points.
First, the rubric segmental glomerulosclerosis in the
Oxford classification actually comprises at least two different
lesions. First is focal segmental glomerulosclerosis (FSGS), a
separate category in the Haas classification of IgAN.3 Second
are the sequelae of segmental proliferative and necrotic
lesions. Segmental lesions occurred in 66% of our patients.
Of these, 47% had visible intracapillary hyalinosis lesions
and, in our opinion, represent definite FSGS. The other 53%
had only capsular adhesions and epithelial changes, and thus
were indeterminate, possibly representing FSGS but also
possibly other pathological processes. Those with frank FSGS
had a poor prognosis, with 50% ending on dialysis,
compared with 4.1% of patients without segmental lesions
(P¼ 0.00001). Those with indeterminate segmental lesions
had a course intermediate between the other two groups,
with 36.1% ending on dialysis.
Another lesion not included in the Oxford classification
is thrombotic microangiopathy (TMA). TMA has been
described in IgAN, usually associated with severe/malignant
hypertension.4 TMA was present in 53% of our patients,
including 26% of normotensive patients. It has a poor
prognosis, with 47% of patients ending on dialysis, compared
with 9% of patients without TMA (P¼ 0.000002). Thus,
TMA must be considered with care in evaluating biopsies
with IgAN, and should perhaps be added to the Oxford
classification.
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We thank Dr Hill and colleagues for their comments.1 It is
likely that the Oxford classification will evolve, as evidence
for a clinical impact of other histological lesions emerges
from validation studies in other patient groups. Thrombo-
tic microangiopathy was a rare lesion in the cohort used
for developing the Oxford classification, and as a result was
not included in the final formulation.
The nature and pathogenesis of segmental sclerosing lesions
in immunoglobulin A (IgA) nephropathy are yet to be
determined. We agree that focal segmental glomerulosclerosis
(FSGS) may arise through at least two routes, as a result of
podocyte injury or of fibrosis within proliferating and
necrotizing lesions. The mechanism of podocyte injury in
IgA nephropathy is unclear; although it is suggested that FSGS
and IgA deposition are not directly related,2 the frequent
concurrence of these lesions would suggest a pathogenetic link.
In primary FSGS, the presence of hyalinosis does not predict
prognosis.3 However, the observation that intracapillary
hyalinosis identifies a poor prognostic subgroup in segmental
sclerosis associated with IgA nephropathy, and possibly a
different pathogenesis to those lesions without hyalinosis,
deserves further study. It is something that could be analyzed
in our group of patients. If confirmed, and importantly if the
subclassification of FSGS lesions is demonstrated to be
reproducible, then this may potentially be incorporated into
future modifications of the Oxford classification.
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To the Editor: We agreed with Freedberg’s1 article, which
proposed the importance of muscle mass in evaluating each
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